移至主內容

Benzodiazepines for restless legs syndrome

Background

Restless legs syndrome (RLS) is a common and distressing disease affecting 5% to 15% of the population. Many physicians are still unaware of the disease and do not recognize its symptoms. This disease can affect sleep significantly, impairing quality of life. There is a need for safe and effective treatment for RLS. Current treatments include dopamine agonists, anticonvulsants, and opioids.

Question

Are benzodiazepines effective and safe for people with RLS?

Methods

We searched the literature for studies in any language, published or not, that considered benzodiazepines for the treatment of RLS.

Results

No studies were included in the review.

Discussion

Benzodiazepines have been used for a long time in people with RLS, because these drugs help sleep initiation and maintenance. As there was no properly conducted systematic review on the effectiveness of benzodiazepines, we performed one on this topic.

Conclusion

This systematic review shows that there is no good data to support or refute the use of benzodiazepines to treat symptoms of RLS.

背景

Restless legs syndrome (RLS) is a common disease affecting about 5% to 15% of the population. Symptoms of RLS can be severe in a minority of and can have a major impact on sleep, mostly sleep initiation, and quality of life. Benzodiazepines are drugs that can induce and maintain sleep and, hence, intuitively are thought to be beneficial to people with RLS. Altough benzodiazepines, particularly clonazepam, are used to treat RLS symptoms, a systematic review done by the American Academy of Sleep Medicine stated that benzodiazepines should not be used as a first-line treatment, although could be used as a coadjuvant therapy.

目的

To evaluate the efficacy and safety of benzodiazepine compared to placebo or other treatment for idiopathic RLS, including unconfounded trials comparing benzodiazepines versus open control.

搜尋策略

In March 2016 we searched CENTRAL, MEDLINE, Embase and LILACS We checked the references of each study and contacted study authors to identify any additional studies. We considered studies published in any language.

選擇標準

Randomised clinical trials of benzodiazepine treatment in idiopathic RLS.

資料收集與分析

We did not perform data collection and analysis, since we did not include any studies,

主要結果

We did not identify any studies that met the inclusion criteria of the review. Two cross-over studies are awaiting classification because the cross-over trials did not give data at the end of the first cross-over period.

作者結論

The effectiveness of benzodiazepines for RLS treatment is currently unknown.

引用文獻
Carlos K, Prado GF, Teixeira CDM, Conti C, de Oliveira MM, Prado LBF, Carvalho LBC. Benzodiazepines for restless legs syndrome. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No.: CD006939. DOI: 10.1002/14651858.CD006939.pub2.

我們對Cookie的使用

我們使用必要的 cookie 使我們的網站正常運作。我們還希望設置可選擇分析的 cookie,以幫助我們進行改進網站。除非您啟用它們,否則我們不會設置可選擇的 cookie。使用此工具將在您的設備上設置 cookie,以記住您的偏好。您隨時可以隨時通過點擊每個頁面下方的「Cookies 設置」連結來更改 Cookie 偏好。
有關我們使用 cookie 的更多詳細資訊,請參閱我們的 cookie 頁面

接受所有
配置